Hong Ryeol Jeon

This inventor holds 10 USPTO granted patents and 8 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Ctc Bio, Inc., Il-Yang Pharm. Co., Ltd, CTO Bio, Inc.. Active years: 2001-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hong Ryeol Jeon. Retrieved from https://idiyas.com/inventor/hong-ryeol-jeon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 8)

% Patents Active = 100.0

CIPO Patents = 2

EPO Patents = 2 (Patent Applications = 10)

Average Co-Inventor Count = 5.3

ph-index = 2

Forward Citations = 35(Granted Patents)

Location History:

Suwon, KR (2001)
Suwon-shi, KR (2002)
Gyeonggi-do, KR (2018 - 2022)
Suwon-si, KR (2018 - 2022)

Company Filing History:

Il-Yang Pharm. Co., Ltd

Years Active: 2001-2022

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11383864 - Capsule filling apparatus (2022-07-12),

2. 11266658 - Preparation, comprising inclusion complex of varenicline or pharmaceutically acceptable salt thereof, for oral administration (2022-03-08),

3. 11116769 - Tadalafil free base-containing film dosage form containing polyethylene glycol-based polymer and/or vinyl pyrrolidone-based polymer as dispersion stabilizer (2021-09-14),

4. 10512610 - Pharmaceutical composition containing clomipramine and preparation method therefor (2019-12-24),

5. 10213437 - Pharmaceutical preparation for masked taste oral administration, containing clomipramine (2019-02-26),

6. 10045993 - Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor (2018-08-14),

7. 10045944 - Pharmaceutical composition containing clomipramine and preparation method therefor (2018-08-14),

8. 10004769 - Lactobacillus brevis G-101 strain and use thereof (2018-06-26),

9. 6365148 - Enteric coated microgranules for stabilizing lactic acid bacteria (2002-04-02),

10. 6280773 - Optimally stabilized microgranule comprising 5-pyrrolyl-2-pyridylmethylsulfinylbenzimidazole derivative (2001-08-28),

Title: Innovations of Hong Ryeol Jeon

Introduction

Hong Ryeol Jeon is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals and medical devices, holding a total of 10 patents. His work focuses on improving drug formulations and delivery systems, showcasing his commitment to enhancing patient care.

Latest Patents

One of his latest patents is a capsule filling apparatus. This innovative device includes a supplying member that supplies a tablet, a moving member that moves the tablet in a preset direction, a catching member that catches the tablet by suction and inserts it into a capsule, and a capsule accommodating member located below the catching member. Another notable patent is for a preparation comprising an inclusion complex of varenicline or a pharmaceutically acceptable salt thereof for oral administration. This formulation effectively masks the bitter taste of the drug, improves its solubility, and enhances the oxidation stability of varenicline, thereby improving the convenience of medication.

Career Highlights

Throughout his career, Hong Ryeol Jeon has worked with several reputable companies, including CTC Bio, Inc. and Il-Yang Pharm. Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in pharmaceutical technology.

Collaborations

He has collaborated with notable colleagues such as Bong-Sang Lee and Do-Woo Kwon, further enriching his work and expanding the impact of his inventions.

Conclusion

Hong Ryeol Jeon is a distinguished inventor whose contributions to the pharmaceutical industry have led to significant advancements in drug formulation and delivery. His innovative patents reflect his dedication to improving patient care and medication efficacy.

Profile summary based on public USPTO records.